TrialNeurology2023

Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial.

Amel Karaa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.